Zacks Investment Research on MSN
Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?
Pfizer PFE will report its third-quarter 2025 earnings on Nov. 4, before market open. The Zacks Consensus Estimate for sales ...
Barchart on MSN
Pfizer Stock: Is Wall Street Bullish or Bearish?
Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells ...
The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...
It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined ...
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter. Looking at the volume ...
Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback